Top-News
Pharmazeutika USA

Plus Therapeutics News

Aktie
WKN:  A3EEZB ISIN:  US72941H5090 US-Symbol:  PSTV
2,00 €
-0,025 €
-1,23%
29.05.24 09:25:10
Handeln Depot/Watchlist
Aktienanzahl *
2,24 Mio.
Marktkapitalisierung *
4,56 Mio. €
Streubesitz
-
Index-Zugehörigkeit
Nasdaq Composite Index
IR-Website
zur Website
*Stand: 01.05.2023

Plus Therapeutics News

13.11.23 - PR Newswire
Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals?
Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals? PR Newswire
11.09.23 - PR Newswire
Thinking about buying stock in Plus Therapeutics, BioLine RX, Flora Growth, Emx Royalty, or Trevena?
Thinking about buying stock in Plus Therapeutics, BioLine RX, Flora Growth, Emx Royalty, or Trevena? PR Newswire
08.09.23 - PR Newswire
Thinking about buying stock in iCoreConnect, Novo Integrated Sciences, Plus Therapeutics, Smith & Wesson Brands, or Neubase Therapeutics?
Thinking about buying stock in iCoreConnect, Novo Integrated Sciences, Plus Therapeutics, Smith & Wesson Brands, or Neubase Therapeutics? PR Newswire
18.08.22 - PR Newswire
Thinking about buying stock in Plus Therapeutics, Mind Medicine, AMC Entertainment, Rigel Pharmaceuticals, or Greenbox POS?
Thinking about buying stock in Plus Therapeutics, Mind Medicine, AMC Entertainment, Rigel Pharmaceuticals, or Greenbox POS? PR Newswire
15.08.22 - PR Newswire
Thinking about buying stock in Plus Therapeutics, Unity Biotechnology, PlayAGS, Torrid, or Bed Bath & Beyond?
Thinking about buying stock in Plus Therapeutics, Unity Biotechnology, PlayAGS, Torrid, or Bed Bath & Beyond? PR Newswire
06.01.22 - PR Newswire
Thinking about buying stock in Freeline Therapeutics, Alterity Therapeutics, Siyata Mobile, Plus Therapeutics, or Nine Energy Service?
Thinking about buying stock in Freeline Therapeutics, Alterity Therapeutics, Siyata Mobile, Plus Therapeutics, or Nine Energy Service? PR Newswire
04.01.22 - PR Newswire
Thinking about buying stock in Plus Therapeutics, Neurobo Pharmaceuticals, Flora Growth, Paysign, or Sio Gene Therapies?
Thinking about buying stock in Plus Therapeutics, Neurobo Pharmaceuticals, Flora Growth, Paysign, or Sio Gene Therapies? PR Newswire
02.09.21 - PR Newswire
Thinking about buying stock in Tiziana Life Sciences, Plus Therapeutics, ChargePoint, Support.com, or INmune Bio?
Thinking about buying stock in Tiziana Life Sciences, Plus Therapeutics, ChargePoint, Support.com, or INmune Bio? PR Newswire
04.05.21 - PR Newswire
Thinking about buying stock in Plus Therapeutics, AMC Entertainment, ProQR Therapeutics, Nokia, or Diana Shipping?
Thinking about buying stock in Plus Therapeutics, AMC Entertainment, ProQR Therapeutics, Nokia, or Diana Shipping? PR Newswire
26.02.21 - PR Newswire
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics?
Thinking about buying stock in Powerbridge Technologies, BioCryst Pharma, Oramed Pharma, Ampio Pharma, or Plus Therapeutics? PR Newswire
12.02.21 - PR Newswire
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech?
Thinking about buying stock in Can Fite Biopharma, Celsion Corp, Remark Holdings, Plus Therapeutics, or SenesTech? PR Newswire
12.11.20 - ACCESSWIRE
Plus Therapeutics to Present at the virtual Fall Investor Summit on November 16th-18th
NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Plus Therapeutics (NASDAQ:PSTV), is a clinical-​stage pharmaceutical company whose radiotherapeutic portfolio is ...
16.04.20 - ACCESSWIRE
Plus Therapeutics to Present at the Planet MicroCap Showcase Virtual Investor Conference 2020
AUSTIN, TX / ACCESSWIRE / April 16, 2020 / Plus Therapeutics, Inc. (NASDAQ:PSTV) (the "Company"), today announced that it will be presenting at the Planet MicroCap Showcase ...

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »